Mercator MedSystems has partnered with Shenzhen Salubris Pharmaceuticals to introduce the Bullfrog® Micro-Infusion Device into the rapidly growing medical device market in China.

Target Information

The Bullfrog® Micro-Infusion Device, developed by Mercator MedSystems, is a sophisticated medical device cleared by the FDA and marked by CE. It features a unique balloon that deploys a micro-needle through the vessel wall, enabling the effective infusion of drugs or biologics directly around arteries or veins. This method allows for precise therapeutic interventions to target local tissues, utilizing X-ray contrast agents for real-time visual feedback during procedures. This device aims to enhance the healing process following mechanical interventions.

Industry Overview in China

China's medical device market is experiencing robust growth, driven by advancements in technology and an increasing demand for innovative healthcare solutions. The rapid urbanization and an aging population are key factors propelling the market forward, with cardiovascular diseases being a leading health concern. The Chinese government has been supportive in promoting the development of new medical technologies, underlining its commitment to elevate healthcare standards.

The interventional cardiology sector, in particular, is witnessing significant investments as healthcare providers seek to adopt cutting-edge devices that can improve patient outcomes. With increasin